Business
Why the Race Oncology (ASX:RAC) share price is rocketing 10% higher
The Race Oncology Ltd (ASX: RAC) share price has been a very strong performer on Thursday.
In morning trade, the precision oncology company’s shares are up 10% to $3.38.
Why is the Race Oncology share price storming higher?
Investors have been buying the company’s shares following the release of a positive announcement this morning.
That announcement revealed details of a recent scientific publication in the prestigious journal Nature Communication.
According to the release, the publication confirms that its phase 2/3 cancer drug Bisantrene is a highly effective inhibitor of the Fat Mass and Obesity associated protein (FTO).
The release notes that the independent work was performed by a research team at the University of…
-
General17 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General9 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
General16 hours agoWarner Bros Discovery board rejects rival $163bn bid from Paramount
-
General21 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat